<?xml version="1.0" encoding="UTF-8"?>
<author-notes>
 <corresp id="c001">*Correspondence: Andreas Michalsen, 
  <email>Andreas.Michalsen@charite.de</email>
 </corresp>
 <fn fn-type="edited-by">
  <p>
   <bold>Edited by:</bold>
   <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/480586/overview" xmlns:xlink="http://www.w3.org/1999/xlink">Jiang-Jiang Qin</ext-link>, Institute of Cancer and Basic Medicine (CAS), China
  </p>
 </fn>
 <fn fn-type="edited-by">
  <p>
   <bold>Reviewed by:</bold>
   <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1057144/overview" xmlns:xlink="http://www.w3.org/1999/xlink">Maja Kozarski</ext-link>, University of Belgrade, Serbia
  </p>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/23729/overview" xmlns:xlink="http://www.w3.org/1999/xlink">Michelle Martinez-Montemayor</ext-link>, Central University of the Caribbean, Puerto Rico
  </p>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/50413/overview" xmlns:xlink="http://www.w3.org/1999/xlink">Jan Martel</ext-link>, Chang Gung University, Taiwan
  </p>
  <p>
   <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/679684/overview" xmlns:xlink="http://www.w3.org/1999/xlink">Ivette Suarez-Arroyo</ext-link>, Central University of the Caribbean, Puerto Rico
  </p>
 </fn>
 <fn fn-type="other">
  <p>This article was submitted to Pharmacology of Anti-Cancer Drugs, a section of the journal Frontiers in Pharmacology</p>
 </fn>
</author-notes>
